7Holland RW, Nimmo CM. Transitions, part1:Beyond pharmaceutical ca re. Am JHealth-Syst Pharm, 1999,56:1758
8Khan MA, Herzog CA, Peter JV St., et al. The prevalence of cardia c valvularinsufficiency assessed by transthoracic echocardiography in obese pat ients treated withappetite-suppressant drugs. N Engl J Med, 1998, 339:713
9Hirsch J. Magic bullet for obesity. BMJ, 1998,317:1136
10Weissman NJ, Tighe JF, Gottdiener, et al. An assessment of heart-valveabnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramineor placebo. N Engl J Med, 1998,339:725
